clinical trial glp 1 Obesity Trials New GLP-1 clinical trial data
Description
These are fundamentally different products operating through fundamentally different mechanisms at fundamentally different scales of effectiveness

STEP-UP, a 72-week clinical trial carried out to study the weight loss effects of semaglutide (Wegovy), found that people lost an average 21% of their body weight after taking the 7.2mg maintenance dose
Chronic GLP-1 receptor activation could produce sustained reductions in CGRP, ongoing anti-inflammatory effects, and persistent intracranial pressure management

Mentlein et al., 1993

Patients may also qualify for pilot programs where they can receive reduced pricing in exchange for feedback on their experience. After doing a test sign-up during my secret shopper research, MyStart offered me a $75 discount on both compounded semaglutide and tirzepatide